Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
The potential risks of equine serum therapy in transmitting new infectious diseases: lessons from a post-pandemic era.
Abstract: No abstract available
Publication Date: 2024-02-14 PubMed ID: 38420034PubMed Central: PMC10899399DOI: 10.3389/fpubh.2024.1366929Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Cite This Article
APA
Pucca MB, Camphora AL.
(2024).
The potential risks of equine serum therapy in transmitting new infectious diseases: lessons from a post-pandemic era.
Front Public Health, 12, 1366929.
https://doi.org/10.3389/fpubh.2024.1366929 Publication
Researcher Affiliations
- Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Campus Araraquara, São Paulo, Brazil.
- Independent Researcher on Intersections of Modern and Contemporary Equine Cultures, Rio de Janeiro, Brazil.
MeSH Terms
- Horses
- Animals
- Pandemics
- Communicable Diseases / therapy
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References
This article includes 32 references
- Laustsen AH, María Gutiérrez J, Knudsen C, Johansen KH, Bermúdez-Méndez E, Cerni FA. Pros and cons of different therapeutic antibody formats for recombinant antivenom development.. Toxicon (2018) 146:151–75.
- Burnouf-Radosevich M, Burnouf T, Huart JJ. A pasteurized therapeutic plasma.. Infusionsther Transfusionsmed (1992) 19:91–4.
- Burnouf T, Griffiths E, Padilla A, Seddik S, Stephano MA, Gutiérrez J-M. Assessment of the viral safety of antivenoms fractionated from equine plasma.. Biologicals (2004) 32:115–28.
- Gröner A, Broumis C, Fang R, Nowak T, Popp B, Schäfer W. Effective inactivation of a wide range of viruses by pasteurization.. Transfusion (2018) 58:41–51.
- Horowitz B, Piët MP, Prince AM, Edwards CA, Lippin A, Walakovits LA. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.. Vox Sang (1988) 54:14–20.
- Burnouf T, Radosevich M. Affinity chromatography in the industrial purification of plasma proteins for therapeutic use.. J Biochem Biophys Methods (2001) 49:575–86.
- Ivan A, Indrei LL. Emergence of transmissible disorders, a continuous process-a new type of viral meningoencephalitis.. Rev Med Chir Soc Med Nat Iasi (2000) 104:51–5.
- Jo WK, de Oliveira-Filho EF, Rasche A, Greenwood AD, Osterrieder K, Drexler JF. Potential zoonotic sources of SARS-CoV-2 infections.. Transbound Emerg Dis (2021) 68:1824–34.
- Kaaden OR, Eichhorn W, Essbauer S. Recent developments in the epidemiology of virus diseases.. J Vet Med B Infect Dis Vet Public Health (2002) 49:3–6.
- Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E.. Vox Sang (2000) 79:72–4.
- Roy CJ, Reed DS, Wilhelmsen CL, Hartings J, Norris S, Steele KE. Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs.. Virol J (2009) 6:170.
- Monath TP, Emerson JK, Kemp GE, Poland JD, Cholas G, Webb PA. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups.. Am J Trop Med Hyg (1987) 36:177–82.
- Epstein JH, Baker ML, Zambrana-Torrelio C, Middleton D, Barr JA, DuBovi E. Duration of maternal antibodies against canine distemper virus and hendra virus in pteropid bats.. PLoS ONE (2013) 8:e67584.
- Chancey C, Grinev A, Volkova E, Rios M. The global ecology and epidemiology of West Nile Virus.. Biomed Res Int (2015) 2015:1–20.
- Ziegler U, Santos PD, Groschup MH, Hattendorf C, Eiden M, Höper D. West Nile virus epidemic in Germany triggered by epizootic emergence, 2019.. Viruses (2020) 12:448.
- Araujo FAA. Raiva Humana no Brasil, 1992 - 2001. (2002).
- Green SL, Smith LL, Vernau W, Beacock SM. Rabies in horses: 21 cases (1970-1990). J Am Vet Med Assoc (1992) 200:1133–7.
- Kumar B, Manuja A, Gulati B, Virmani N, Tripathi BN. Zoonotic viral diseases of equines and their impact on human and animal health. Open Virol J (2018) 12:80–98.
- Legere RM, Allegro AR, Affram Y, da Silveira BP, Fridley JL, Wells KM. Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency. Am J Vet Res (2023) 84:ajvr.23.06.0132.
- Pusterla N, Chaillon A, Ignacio C, Smith DM, Barnum S, Lawton KOY. SARS-CoV-2 seroconversion in an adult horse with direct contact to a COVID-19 individual. Viruses (2022) 14:1047.
- Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL. Global trends in emerging infectious diseases. Nature (2008) 451:990–3.
- Butantan . Portal do Butantan. Soros e Bulas. (2023). Available online at: https://butantan.gov.br/soros-e-vacinas/soros (accessed August 31, 2023).
- McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 348:552–4.
- Camphora A, Pucca M. Horses used for large-scale production of immunoglobulins: an inter-species approach. Int Anim Health J (2022) 8:12–6.
- Pucca MB, Cerni FA, Peigneur S, Arantes EC, Tytgat J, Barbosa JE. Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities. J Immunotoxicol (2014) 11:133–40.
- Ahmadi S, Pucca MB, Jürgensen JA, Janke R, Ledsgaard L, Schoof EM. An methodology for discovering broadly-neutralizing monoclonal antibodies. Sci Rep (2020) 10:10765.
- Knudsen C, Ledsgaard L, Dehli RI, Ahmadi S, Sørensen CV, Laustsen AH. Engineering and design considerations for next-generation snakebite antivenoms. Toxicon (2019) 167:67–75.
- Sørensen CV, Fernández J, Adams AC, Wildenauer HHK, Schoffelen S, Ledsgaard L. Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper. Nat Commun (2024) 15:173.
- Føns S, Ledsgaard L, Nikolaev MV, Vassilevski AA, Sørensen CV, Chevalier MK. Discovery of a recombinant human monoclonal immunoglobulin G antibody against α-latrotoxin from the mediterranean Black Widow Spider (). Front Immunol (2020) 11:587825.
- Ledsgaard L, Wade J, Jenkins TP, Boddum K, Oganesyan I, Harrison JA. Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes. Nat Commun (2023) 14:682.
- Campos LB, Pucca MB, Silva LC, Pessenda G, Filardi BA, Cerni FA. Identification of cross-reactive human single-chain variable fragments against phospholipases A2 from Lachesis muta and Bothrops spp venoms. Toxicon 2020 184:116–21.
- Albulescu L-O, Xie C, Ainsworth S, Alsolaiss J, Crittenden E, Dawson CA. A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. Nat Commun 2020 11:6094.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
